New Hampshire Finalizes Opioid Settlement with Allergan Limited
Trusted by teams at
Description
The State of New Hampshire and Allergan Limited entered into a court-approved settlement as part of a nationwide opioid litigation settlement. Under the terms, Allergan will make annual payments to abate opioid-related harms, with payment years scheduled through 2029. The consent judgment includes injunctive relief, broad releases, and resolves all state and subdivision claims against Allergan Limited.
Contract Details
Contract Amount
See Allergan Public Global Opioid Settlement Agreement; up to $2,372,972,184.12 nationwide (maximum settlement global amount). New Hampshire amount not specified in this excerpt.
Vendor
ALLERGAN LIMITED
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Payment Year 1 is 2023, Payment Year 2 is 2024, ... through Payment Year 7 (2029). Payments scheduled annually through July 15, 2029.
Renewal Date
2029-07-15
Renewal Info
Settlement is not renewable; amendments require written consent by both parties and court approval.
More from ALLERGAN LIMITED
Issuing Agency
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.